|
OXFORD, UK, September 4th, 2015
PharmaVentures is pleased to announce that it acted as advisor to
Douglas Pharmaceuticals,
New Zealand's largest pharmaceutical manufacturer, in acquiring
from Auckland-based Vital Foods
their Phloe® product line in New Zealand for an undisclosed sum. The deal, completed on 1st September, includes
an option for additional territories.
The sale of the Phloe® product line to Douglas Pharmaceuticals allows for the growth of Phloe® in New Zealand and enables Vital Foods to focus more effectively on the international market for Phloe® products.
Phloe® Bowel Health contains Zyactinase®, a proprietary kiwifruit extract with a unique mode of action derived from naturally occurring prebiotics, enzymes and fibre that aids regular and efficient bowel function.
Aki von Roy, Associate Director Asia-Pacific, PharmaVentures, said: "
We are delighted to support Douglas Pharmaceuticals in its plans for growth both in New Zealand and globally
".
Fintan Walton, Chief Executive, PharmaVentures, added: "This latest deal reflects the growing number of global deals that we have achieved in recent years"
For the past 23 years, PharmaVentures has acted as advisor to over 700 global pharmaceutical and biotechnology clients in transactions; covering licensing, mergers, acquisitions, divestments and joint venture activities for companies.
- ends -
About PharmaVentures, Ltd
PharmaVentures is a premier transaction advisory firm; a leader in partnering, M&A deals and strategic alliances.
An unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes them uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.
Their services include:
- * M&A (divestments, mergers, acquisitions and strategic transactions)
- * Strategy (commercialisation, deal strategy, due diligence, market entry)
- * Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
- * Licensing (in and out licensing)
- * Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
PharmaVentures is based in Oxford, UK, employs over 20 professionals and has associates in North America, Europe, Latin America and Asia-Pacific.
FOR FURTHER INFORMATION, CONTACT:
Dr Fintan Walton
Chief Executive
PharmaVentures Ltd
+44 1865 332700
|
